NASH, non-alcoholic steatohepatitis
Risk Factors Requiring Elevated Screening Personal history of any eating disorder, including sub-threshold presentations, adolescent dieting pathology, or ARFID Family history of restrictive eating, excessive exercise, or diet-culture-driven food restriction High dietary restraint, rigid food rules, or BMI-focused identity Any prior mental health diagnosis doubles two-year eating disorder risk post-initiation Adolescent and young adult patients developmentally most vulnerable Off-label use in patients without metabolic comorbidities the cosmetic use population most likely to include subclinical disordered eating What the Physiology Actually Produces in a Restrictive Mind For a patient with anorexia nervosa in whom the ego-syntonic experience of not being hungry is already rewarding GLP-1-mediated appetite suppression does not feel like a side effect to manage
Antioxidant Protection: Defends cells against free radicals
Many patients who expected to be prescribed insulin are now prescribed GLP-1 drugs instead, further blurring the line between the two categories in the public consciousness
RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway
10.1016/j.freeradbiomed.2019.04.008 72 Villas-BasJ
